7-6621150-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017560.3(ZNF853):āc.159G>Cā(p.Glu53Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000657 in 152,178 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_017560.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF853 | NM_017560.3 | c.159G>C | p.Glu53Asp | missense_variant | 3/3 | ENST00000457543.4 | NP_060030.1 | |
ZNF853 | NM_001353546.2 | c.114G>C | p.Glu38Asp | missense_variant | 3/3 | NP_001340475.1 | ||
ZNF853 | XM_011515438.4 | c.237G>C | p.Glu79Asp | missense_variant | 4/4 | XP_011513740.1 | ||
ZNF853 | XM_011515439.4 | c.192G>C | p.Glu64Asp | missense_variant | 4/4 | XP_011513741.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000121 AC: 1AN: 82904Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 40940
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 7.60e-7 AC: 1AN: 1316502Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 640974
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152178Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74340
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 09, 2024 | The c.159G>C (p.E53D) alteration is located in exon 3 (coding exon 3) of the ZNF853 gene. This alteration results from a G to C substitution at nucleotide position 159, causing the glutamic acid (E) at amino acid position 53 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at